Atlas Trials

Persistent SARS-CoV-2 Infection in Children With Cancer and Impaired Immune Responsiveness

Clinical trial NCT05172063 · UNKNOWN

Trial details

NCT number
NCT05172063
Sponsor
Children's Cancer Hospital Egypt 57357
Status
UNKNOWN
Study type
OBSERVATIONAL
Children With CancerSARS-CoV-2 Infection
Start date
2022-01-01
Primary completion
2023-03-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.